date:Mar 26, 2019
typically associated with a number of lipid-lowering drugs.
Other related parameters, such as fasting blood glucose, homocysteine levels, and apo-B/apo lipoprotein levels, also tended to lower. This potentially widens Tri-lows scope for targeting diabetic dyslipidemia.
Tri-Low delivers the full spectrum of bioactive ingredients extracted from wild, fresh, ripe Indian gooseberry fruit (Phyllanthus emblica aka amla). It is the first of its kind standardised with diacylglycerides of ALA - a-Lino